Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

JW Vogel, N Corriveau-Lecavalier… - Nature Reviews …, 2023 - nature.com
Neurodegenerative diseases are the most common cause of dementia. Although their
underlying molecular pathologies have been identified, there is substantial heterogeneity in …

Network models to enhance the translational impact of cross-species studies

JK Brynildsen, K Rajan, MX Henderson… - Nature Reviews …, 2023 - nature.com
Neuroscience studies are often carried out in animal models for the purpose of
understanding specific aspects of the human condition. However, the translation of findings …

Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes

V Montal, I Diez, CM Kim, W Orwig… - Science translational …, 2022 - science.org
A key hallmark of Alzheimer's disease (AD) pathology is the intracellular accumulation of tau
protein in the form of neurofibrillary tangles across large-scale networks of the human brain …

The anti-Alzheimer potential of novel spiroindolin-1, 2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents

H Pourtaher, A Hasaninejad, S Zare, N Tanideh… - Scientific Reports, 2023 - nature.com
In this study, a new series of spiro indolin-1, 2-diazepine were designed, synthesized, and
screened for their cholinesterase inhibitory activities. A novel, green, high-yielding approach …

Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms

AF Khan, Y Iturria-Medina - Translational Psychiatry, 2024 - nature.com
From Alzheimer's disease to amyotrophic lateral sclerosis, the molecular cascades
underlying neurodegenerative disorders remain poorly understood. The clinical view of …

[HTML][HTML] Connectome-based biophysics models of Alzheimer's disease diagnosis and prognosis

J Torok, C Anand, P Verma, A Raj - Translational Research, 2023 - Elsevier
With the increasing prevalence of Alzheimer's disease (AD) among aging populations and
the limited therapeutic options available to slow or reverse its progression, the need has …

[HTML][HTML] Cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer's disease

J Torok, PD Maia, C Anand, A Raj - bioRxiv, 2023 - ncbi.nlm.nih.gov
Neurodegenerative diseases such as Alzheimer's disease (AD) exhibit pathological
changes in the brain that proceed in a stereotyped and regionally specific fashion, but the …

Directionality bias is necessary to explain spatiotemporal progression of pathology in mouse models of tauopathy

J Torok, C Mezias, A Raj - bioRxiv, 2024 - biorxiv.org
Mounting evidence implicates trans-synaptic connectome-based spread as a shared
mechanism behind different tauopathic conditions, yet also suggests there is divergent …

Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome

C Anand, J Torok, F Abdelnour, P Maia, A Raj - bioRxiv, 2024 - biorxiv.org
Brain regions in Alzheimer's (AD) exhibit distinct vulnerability to the disease's hallmark
pathology, with the entorhinal cortex and hippocampus succumbing early to tau tangles …

Integrating neurotransmitter receptor architecture in whole-brain computational models of neurodegenerative disease progression

A Khan - 2024 - escholarship.mcgill.ca
Alzheimer's disease (AD) and Parkinson's disease (PD) are among the prevailing causes of
dementia and movement disorder, respectively. These neurodegenerative diseases are …